FDA Approves ARSENIC TRIOXIDE — Zydus Pharmaceuticals USA Inc.

# FDA Approves Arsenic Trioxide Generic from Zydus Pharmaceuticals The FDA has approved Zydus Pharmaceuticals USA Inc.'s generic arsenic trioxide intravenous formulation, expanding treatment options for acute promyelocytic leukemia and potentially reducing costs for patients and healthcare systems. The approval is expected to increase competition in the arsenic trioxide market and drive down pricing as generic alternatives become available to complement existing branded therapies.